Balloon Valvuloplasty Devices Market Trends

Balloon Valvuloplasty Devices Market Trends

The increasing prevalence of valvular heart disease is a significant driver for balloon valvuloplasty devices industry. Risk factors for valvular heart disease (VHD), including pulmonary arterial hypertension, hypercholesterolemia, diabetes, and smoking, are becoming increasingly prevalent worldwide.  
 

• According to the Multidisciplinary Digital Publishing Institute (MDPI), in 2023, the prevalence of rheumatic heart disease, the most common valvular heart disease (affecting approximately 41 million people), has been rising in developing nations, likely due to the expansion of the young adult population.
   
• Balloon valvuloplasty procedures have expanded beyond their traditional indications to include a broader spectrum of patients with various types and severities of valvular stenosis or regurgitation. Improved cardiology information system, device technology, procedural techniques, and patient selection criteria have widened the applicability of balloon valvuloplasty, making it a viable treatment option for a larger proportion of patients with VHD.
   
• Moreover, the prevalence of valvular heart disease is not limited to developed countries, it is also increasing in emerging markets due to demographic shifts, urbanization, and changes in lifestyle factors. As healthcare infrastructure improves and access to advanced medical treatments expands in these regions, the demand for balloon valvuloplasty devices is expected to grow.